Ubs Group Ag Neuronetics, Inc. Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Neuronetics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 112,114 shares of STIM stock, worth $390,156. This represents 0.0% of its overall portfolio holdings.

Number of Shares

112,114

Previous 403,624 72.22%

Holding current value

$390,156

Previous $601,000 31.45%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$1.49 - $5.54 $434,349 - $1.61 Million	-291,510 Reduced 72.22%	112,114 $412,000
Q4 2024 Feb 14, 2025	BUY	$0.59 - $1.49 $234,297 - $591,699	397,114 Added 6100.06%	403,624 $601,000
Q3 2024 Nov 14, 2024	SELL	$0.73 - $2.0 $43,558 - $119,338	-59,669 Reduced 90.16%	6,510 $4,000
Q2 2024 Aug 13, 2024	BUY	$1.73 - $4.81 $106,680 - $296,608	61,665 Added 1366.08%	66,179 $119,000
Q1 2024 May 13, 2024	BUY	$2.68 - $4.8 $11,853 - $21,230	4,423 Added 4860.44%	4,514 $21,000
Q2 2023 Aug 11, 2023	SELL	$2.07 - $2.92 $2,958 - $4,172	-1,429 Reduced 94.01%	91 $0
Q1 2023 May 12, 2023	SELL	$2.81 - $6.71 $21,563 - $51,492	-7,674 Reduced 83.47%	1,520 $4,000
Q4 2022 Feb 08, 2023	BUY	$2.74 - $6.87 $22,317 - $55,956	8,145 Added 776.45%	9,194 $63,000
Q3 2022 Nov 10, 2022	BUY	$2.35 - $4.66 $2,288 - $4,538	974 Added 1298.67%	1,049 $3,000
Q2 2022 Aug 10, 2022	SELL	$2.09 - $3.71 $9,651 - $17,132	-4,618 Reduced 98.4%	75 $0
Q1 2022 May 16, 2022	SELL	$2.84 - $4.52 $6,739 - $10,725	-2,373 Reduced 33.58%	4,693 $14,000
Q4 2021 Feb 14, 2022	BUY	$3.87 - $6.59 $27,345 - $46,564	7,066 New	7,066 $32,000
Q3 2021 Nov 15, 2021	SELL	$6.22 - $15.54 $13,932 - $34,809	-2,240 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$10.15 - $17.25 $22,736 - $38,640	2,240 New	2,240 $36,000
Q4 2020 Feb 11, 2021	SELL	$4.95 - $11.45 $25,353 - $58,646	-5,122 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$1.82 - $5.87 $8,308 - $26,796	4,565 Added 819.57%	5,122 $25,000
Q2 2020 Jul 31, 2020	SELL	$1.41 - $2.61 $10,548 - $19,525	-7,481 Reduced 93.07%	557 $1,000
Q1 2020 May 01, 2020	SELL	$1.28 - $4.5 $10,698 - $37,611	-8,358 Reduced 50.98%	8,038 $15,000
Q4 2019 Feb 14, 2020	BUY	$4.03 - $9.22 $25,981 - $59,441	6,447 Added 64.8%	16,396 $74,000
Q3 2019 Nov 14, 2019	BUY	$8.31 - $13.03 $82,676 - $129,635	9,949 New	9,949 $83,000
Q2 2019 Aug 14, 2019	SELL	$9.0 - $17.2 $12,456 - $23,804	-1,384 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$13.6 - $19.58 $18,822 - $27,098	1,384 New	1,384 $21,000
Q4 2018 Feb 14, 2019	SELL	$16.0 - $31.84 $24,048 - $47,855	-1,503 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$24.32 - $37.54 $25,876 - $39,942	1,064 Added 242.37%	1,503 $48,000
Q2 2018 Aug 14, 2018	BUY	$26.61 - $27.78 $11,681 - $12,195	439 New	439 $12,000

Others Institutions Holding STIM

# of Institutions

109

Shares Held

19.5M

Call Options Held

96.2K

Put Options Held

58.4K

View Full List

About Neuronetics, Inc.

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $94M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

More about STIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account